Finance Watch: Will Biotech Stock Rebound Keep IPOs Coming?
Rain Therapeutics, Impel NeuroPharma Go Public As Valuations Rise
Public Company Edition: The Nasdaq Biotechnology Index appears to be in recovery from an earlier slide, but still has ground to make up. Also, Jazz sold $1.5bn worth of notes and Zai Lab closed an $823.9m follow-on offering.
